Log In
Print
BCIQ
Print
Print this Print this
 

Octreolin, octreotide acetate (RG3806)

  Manage Alerts
Collapse Summary General Information
Company Chiasma Inc.
DescriptionOral formulation of octreotide acetate that utilizes Transient Permeability Enhancer technology
Molecular Target Growth hormone receptor
Mechanism of ActionGrowth hormone receptor antagonist
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today